Depression screening and patient outcomes in cardiovascular care: a systematic review.

CONTEXT Several practice guidelines recommend that depression be evaluated and treated in patients with cardiovascular disease, but the potential benefits of this are unclear. OBJECTIVE To evaluate the potential benefits of depression screening in patients with cardiovascular disease by assessing (1) the accuracy of depression screening instruments; (2) the effect of depression treatment on depression and cardiac outcomes; and (3) the effect of screening on depression and cardiac outcomes in patients in cardiovascular care settings. DATA SOURCES MEDLINE, PsycINFO, CINAHL, EMBASE, ISI, SCOPUS, and Cochrane databases from inception to May 1, 2008; manual journal searches; reference list reviews; and citation tracking of included articles. STUDY SELECTION We included articles in any language about patients in cardiovascular care settings that (1) compared a screening instrument to a valid major depressive disorder criterion standard; (2) compared depression treatment with placebo or usual care in a randomized controlled trial; or (3) assessed the effect of screening on depression identification and treatment rates, depression, or cardiac outcomes. DATA EXTRACTION Methodological characteristics and outcomes were extracted by 2 investigators. RESULTS We identified 11 studies about screening accuracy, 6 depression treatment trials, but no studies that evaluated the effects of screening on depression or cardiovascular outcomes. In studies that tested depression screening instruments using a priori-defined cutoff scores, sensitivity ranged from 39% to 100% (median, 84%) and specificity ranged from 58% to 94% (median, 79%). Depression treatment with medication or cognitive behavioral therapy resulted in modest reductions in depressive symptoms (effect size, 0.20-0.38; r(2), 1%-4%). There was no evidence that depression treatment improved cardiac outcomes. Among patients with depression and history of myocardial infarction in the ENRICHD trial, there was no difference in event-free survival between participants treated with cognitive behavioral therapy supplemented by an antidepressant vs usual care (75.5% vs 74.7%, respectively). CONCLUSIONS Depression treatment with medication or cognitive behavioral therapy in patients with cardiovascular disease is associated with modest improvement in depressive symptoms but no improvement in cardiac outcomes. No clinical trials have assessed whether screening for depression improves depressive symptoms or cardiac outcomes in patients with cardiovascular disease.

[1]  J. Tijssen,et al.  Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis , 2004, Psychosomatic medicine.

[2]  P. Bower,et al.  Collaborative care for depression in UK primary care: a randomized controlled trial , 2007, Psychological Medicine.

[3]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[4]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[5]  Ellen Frank,et al.  Assessment and treatment of depression in patients with cardiovascular disease: National heart, lung, and blood institute working group report , 2006, Psychosomatic medicine.

[6]  A. Hubley,et al.  Screening for depression after cardiac events using the Beck Depression Inventory-II and the Geriatric Depression Scale , 2007 .

[7]  A. Schene,et al.  Effects of antidepressant treatment following myocardial infarction , 2007, British Journal of Psychiatry.

[8]  P. Bech,et al.  Postmyocardial Infarction Mortality in Relation to Depression: A Systematic Critical Review , 2005, Psychotherapy and Psychosomatics.

[9]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[10]  B. Thombs,et al.  Prevalence of depression in survivors of acute myocardial infarction , 2007, Journal of General Internal Medicine.

[11]  W. Drevets,et al.  Course of antidepressant treatment drug type, and prescriber's specialty. , 1998, Psychiatric services.

[12]  J. Denollet,et al.  Recognizing Increased Risk of Depressive Comorbidity after Myocardial Infarction: Looking for 4 Symptoms of Anxiety-Depression , 2006, Psychotherapy and Psychosomatics.

[13]  J. Myers,et al.  Psychosocial Interventions for Patients With Coronary Artery Disease: A Meta-analysis , 1996 .

[14]  A. Schene,et al.  Treatment of Post-Myocardial Infarction Depressive Disorder: A Randomized, Placebo-Controlled Trial With Mirtazapine , 2007, Psychosomatic medicine.

[15]  H. Weber.  Kommentar zu: Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002 .

[16]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[17]  Screening for depression: recommendations and rationale. , 2002 .

[18]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[19]  Simon Gilbody,et al.  Should we screen for depression? , 2006, BMJ : British Medical Journal.

[20]  J. Denollet,et al.  Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. , 2001, Psychosomatics.

[21]  Alfred O. Berg,et al.  Screening for Depression: Recommendations and Rationale , 2002, Annals of Internal Medicine.

[22]  J. Coyne,et al.  Screening for depression in medical care: pitfalls, alternatives, and revised priorities. , 2003, Journal of psychosomatic research.

[23]  L. Robins,et al.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. , 1981, Archives of general psychiatry.

[24]  A. Schene,et al.  Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. , 2006, The American journal of psychiatry.

[25]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[26]  H. Wellens,et al.  Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial , 2000, Psychosomatic medicine.

[27]  J. Donoghue,et al.  Antidepressant use in clinical practice: efficacy v. effectiveness , 2001, British Journal of Psychiatry.

[28]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .

[29]  N. Frasure-smith,et al.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.

[30]  H. Wittchen.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. , 1994, Journal of psychiatric research.

[31]  C. Herrmann-Lingen,et al.  Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis , 2004, Psychosomatic medicine.

[32]  J. Rumsfeld,et al.  Depression and cardiovascular disease: a call for recognition. , 2005, Circulation.

[33]  W. Linden,et al.  Psychological treatment of cardiac patients: a meta-analysis. , 2007, European heart journal.

[34]  R. Califf,et al.  Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.

[35]  C. F. Mendes de Leon.  Depression and social support in recovery from myocardial infarction: confounding and confusion. , 1999, Psychosomatic medicine.

[36]  S. Connolly,et al.  Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. , 1999, Psychosomatic Medicine.

[37]  W. Manning,et al.  Randomized trial of a depression management program in high utilizers of medical care. , 2000, Archives of family medicine.

[38]  W. Browner,et al.  Case-finding instruments for depression. Two questions are as good as many. , 1997, Journal of general internal medicine.

[39]  T. Rector,et al.  Measurement of Clinical Efficacy in Studies of Heart Failure , 2022 .

[40]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[41]  M. Irwin,et al.  Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D) , 1999, Archives of internal medicine.

[42]  G. Fricchione,et al.  Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items , 2006, Heart.

[43]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[44]  Lei Wang,et al.  Three options for citation tracking: Google Scholar, Scopus and Web of Science , 2006, Biomedical digital libraries.

[45]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[46]  D. McManus,et al.  Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). , 2005, The American journal of cardiology.

[47]  L. Hedges.  Estimation of effect size from a series of independent experiments. , 1982 .

[48]  R. Spitzer,et al.  The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener , 2003, Medical care.

[49]  C. Mulrow,et al.  Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.

[50]  J Thomas Bigger,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[51]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Journal of the American College of Cardiology.

[52]  Mendes de Leon Cf.  Depression and social support in recovery from myocardial infarction: confounding and confusion. , 1999 .

[53]  Alex J Sutton,et al.  Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. , 2006, Archives of internal medicine.

[54]  A. Heagerty,et al.  The risk factors for depression in first myocardial infarction patients , 2004, Psychological Medicine.

[55]  R. Dawes,et al.  Heuristics and Biases: Clinical versus Actuarial Judgment , 2002 .

[56]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[57]  Robyn M Leventhal,et al.  Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database , 2002, Journal of clinical psychopharmacology.

[58]  R. Spitzer,et al.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.

[59]  Kathleen N Lohr,et al.  Screening for Depression in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[60]  H. Kuper,et al.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. , 2006, European heart journal.

[61]  D. Rubin,et al.  Contrasts and Effect Sizes in Behavioral Research: A Correlational Approach , 1999 .

[62]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[63]  J. Rumsfeld,et al.  Depressive symptoms and health-related quality of life: the Heart and Soul Study. , 2003, JAMA.

[64]  R. Gibbons.  ACC/AHA guideline for management of patients with chronic stable angina , 2003 .

[65]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[66]  W. Katon,et al.  Collaborative care models for depression: time to move from evidence to practice. , 2006, Archives of internal medicine.

[67]  E H Wagner,et al.  Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.

[68]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[69]  J. Ornato,et al.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.

[70]  G. Lip,et al.  Anxiety, depression, and prognosis after myocardial infarction: is there a causal association? , 2003, Journal of the American College of Cardiology.

[71]  Lippincott Williams Wilkins,et al.  ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[72]  Carolyn Rutter,et al.  Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. , 2007, Archives of general psychiatry.

[73]  G. Ramirez,et al.  Identifying depression in primary care: a literature synthesis of case-finding instruments. , 2002, General hospital psychiatry.

[74]  N. Frasure-smith,et al.  Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. , 2008, Archives of general psychiatry.

[75]  T. Sheldon,et al.  Screening and case-finding instruments for depression: a meta-analysis , 2008, Canadian Medical Association Journal.

[76]  M. Berk,et al.  Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. , 2007, General hospital psychiatry.

[77]  D. Bush,et al.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. , 2000, Archives of internal medicine.

[78]  N. Frasure-smith,et al.  Reflections on Depression as a Cardiac Risk Factor , 2005, Psychosomatic medicine.

[79]  W. Katon,et al.  Population-Based Care of Depression: Team Care Approaches to Improving Outcomes , 2008, Journal of occupational and environmental medicine.

[80]  R. Rosenthal,et al.  Meta-analysis: recent developments in quantitative methods for literature reviews. , 2001, Annual review of psychology.

[81]  Paul J Mills,et al.  Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. , 2006, Journal of the American College of Cardiology.

[82]  R. Carney,et al.  Prevalence of Depression in Hospitalized Patients With Congestive Heart Failure , 2003, Psychosomatic medicine.

[83]  M. Bourassa,et al.  Depression and health-care costs during the first year following myocardial infarction. , 2000, Journal of psychosomatic research.